UNifying Imaging with QUantum Entanglement (UNIQUE) Innovative Solutions Opening (ISO)
Key Takeaways
- Set-aside for No Set Aside businesses
- Work to be performed in Washington, DC
- Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Contract Details
- Notice ID
- ARPA-H-SOL-26-162
- Opportunity Type
- Solicitation
- Sub-Agency
- NATIONAL INSTITUTES OF HEALTH
- Office
- ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
- Posted Date
- Thursday, September 24, 2026
- Response Deadline
- Wednesday, December 16, 2026
- PSC Code
- AN13
- Set-Aside
- No Set Aside
- Place of Performance
- Washington, DC, 20005
- Status
- Active
Description
Amendment 01: The Proposers' Day has been updated to October 16th, 2026. The Advanced Research Projects Agency for Health (ARPA-H) is posting this Innovative Solutions Opening (ISO) in support of the UNifying Imaging with QUantum Entanglement (UNIQUE) Program. ARPA-H anticipates that multiple Other Transaction (OT) Agreements will result from this announcement. Interested parties are invited to review the attached UNIQUE-ISO-ARPA-H-SOL-26-162 and UNIQUE ISO Attachments. Additionally, proposers are encouraged to review the separate Special Notice, ARPA-H-SN-26-162, for information regarding the UNIQUE Proposers Day. Special Notice, ARPA-H-SN-26-162, is an independent announcement and is not attached to this ISO announcement. All questions submitted to the ISO will be compiled and addressed.
Why This Opportunity Matters
HEALTH AND HUMAN SERVICES, DEPARTMENT OF is actively seeking qualified contractors for research and development in biotechnology (except nanobiotechnology) with a set-aside for No Set Aside businesses in Washington, DC. This set-aside designation means eligible businesses face reduced competition from larger firms.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
